Immunoinformatics and its relevance to understanding human immune disease

References

• Ehreth J. The global value of vaccination. Vaccine 21, 596–600 (2003).
   PubMed Web of Science ®Google Scholar
• Brusic V, August JT. The changing field of vaccine development in the genomics era. Pharmacogenomics 5(6), 597–600 (2004).
   PubMed Web of Science ®Google Scholar
• Knudsen TB, Kledal TN, Andersen O, Eugen-Olsen J, Kristiansen TB. Severe acute respiratory syndrome – a new coronavirus from the Chinese dragon’s lair. Scand. J. Immunol. 58(3), 277–284 (2003).
   PubMed Web of Science ®Google Scholar
• Chan CH, Chan Y, Shieh HK et al. Phylogenetic analysis of influenza B virus in Taiwan, 1997 to 2001. J. Microbiol. Immunol. Infect. 37(3), 135–144 (2004).
   PubMedGoogle Scholar
• Chopra I. Antibiotic resistance in Staphylococcus aureus: concerns, causes and cures. Expert Rev. Anti-infect. Ther. 1(1), 45–55 (2003).
   PubMedGoogle Scholar
• Mansky LM. HIV mutagenesis and the evolution of antiretroviral drug resistance. Drug Resist. Update 5(6), 219–223 (2002).
   PubMed Web of Science ®Google Scholar
• Berzofsky JA, Terabe M, Oh S et al. Progress on new vaccine strategies for the immunotherapy and prevention of cancer. J. Clin. Invest. 113(11), 1515–1525 (2004).
   PubMed Web of Science ®Google Scholar
• Prescott SL, Jones CA. An update of immunotherapy for specific allergies. Curr. Drug Targets Inflamm. Allergy 1(1), 65–75 (2002).
   PubMedGoogle Scholar
• Cope AP, Feldmann M. Emerging approaches for the therapy of autoimmune and chronic inflammatory disease. Curr. Opin. Immunol. 16(6), 780–786 (2004).
   PubMed Web of Science ®Google Scholar
• Zhang W, Yang H, Kong X et al. Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nature Med. 11(1), 56–62 (2005).
   PubMed Web of Science ®Google Scholar
• De Giovanni C, Nicoletti G, Landuzzi L et al. Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin-12-engineered allogeneic cell vaccine. Cancer Res. 64(11), 4001–4009 (2004).
   PubMedGoogle Scholar
• McDevitt H. Specific antigen vaccination to treat autoimmune disease. Proc. Natl Acad. Sci. USA 101(Suppl. 2), 14627–14630 (2004).
   PubMed Web of Science ®Google Scholar
• Brusic V, Petrovsky N. Immunoinformatics – the new kid in town. Novartis Found. Symp. 254, 3–13 (2003).
   PubMedGoogle Scholar
• Rammensee HG. Immunoinformatics: bioinformatic strategies for better understanding of immune function. Introduction. Novartis Found. Symp. 254, 1–2 (2003).
   PubMedGoogle Scholar
• Brusic V, Zeleznikow J, Petrovsky N. Molecular immunology databases and data repositories. J. Immunol. Methods 238(1–2), 17–28 (2000).
   PubMed Web of Science ®Google Scholar
• Galperin MY. The molecular biology database collection: 2005 update. Nucleic Acids Res. 33, D5–D24 (2005).
   Google Scholar
• Brusic V, Millot M, Petrovsky N, Gendel SM, Gigonzac O, Stelman SJ. Allergen databases. Allergy 58(11), 1093–1100 (2003).
   PubMed Web of Science ®Google Scholar
• Haux R, Ammenwerth E, Herzog W, Knaup P. Healthcare in the information society. A prognosis for the year 2013. Int. J. Med. Inform. 66(1–3), 3–21 (2002).
   PubMed Web of Science ®Google Scholar
• Hasman A, Safran C, Takeda H. Quality of healthcare: informatics foundations. Methods Inf. Med. 42(5), 509–518 (2003).
   PubMedGoogle Scholar
• McDonald S. Indigenous transplant outcomes in Australia: what the ANZDATA registry tells us. Nephrology (Carlton) 9(Suppl. 4), S138–S143 (2004).
   Google Scholar
• DiMichele DM, Kroner BL. The North American Immune Tolerance Registry: practices, outcomes, outcome predictors. Thromb. Haemost. 87(1), 52–57 (2002).
   PubMed Web of Science ®Google Scholar
• Bencsath M, Blaskovits A, Borvendeg J. Biomolecular cytokine therapy. Pathol. Oncol. Res. 9(1), 24–29 (2003).
   PubMedGoogle Scholar
• Girardi M, Knobler R, Edelson R. Selective immmunotherapy through extracorporeal photochemotherapy: yesterday, today, and tomorrow. Hematol. Oncol. Clin. North Am. 17(6), 1391–1403 (2003).
   PubMedGoogle Scholar
• Merrill SJ. Computational models in immunological methods: an historical review. J. Immunol. Methods 216(1–2), 69–92 (1998).
   PubMedGoogle Scholar
• Eskin E, Agichtein E. Combining text mining and sequence analysis to discover protein functional regions. Pac. Symp. Biocomput. 288–299 (2004).
   PubMedGoogle Scholar
• Glenisson P, Coessens B, Van Vooren S, Mathys J, Moreau Y, De Moor B. TXTGate: profiling gene groups with text-based information. Genome Biol. 5(6), R43 (2004).
   Google Scholar
• Karopka T, Scheel T, Bansemer S, Glass A. Automatic construction of gene relation networks using text mining and gene expression data. Med. Inform. Internet Med. 29(2), 169–183 (2004).
   PubMed Web of Science ®Google Scholar
• Brusic V, Petrovsky N, Gendel SM, Millot M, Gigonzac O, Stelman SJ. Computational tools for the study of allergens. Allergy 58(11), 1083–1092 (2003).
   PubMedGoogle Scholar
• Lefranc MP. IMGT-ONTOLOGY and IMGT databases, tools and Web resources for immunogenetics and immunoinformatics. Mol. Immunol. 40(10), 647–660 (2004).
   PubMed Web of Science ®Google Scholar
• Lefranc MP, Giudicelli V, Kaas Q et al. IMGT, the international ImMunoGeneTics information system®. Nucleic Acids Res. 33, D593–D597 (2005).
   PubMedGoogle Scholar
• Giudicelli V, Chaume D, Lefranc MP. IMGT/V-QUEST, an integrated software for immunoglobulin and T-cell receptor V-J and V-D-J rearrangement analysis. Nucleic Acids Res. 32, W435–W440 (2004).
   PubMed Web of Science ®Google Scholar
• Monod MY, Giudicelli V, Chaume D, Lefranc MP. IMGT/JunctionAnalysis: the first tool for the analysis of the immunoglobulin and T-cell receptor complex V-J and V-D-J JUNCTIONs. Bioinformatics 20, I379–I385 (2004).
   Web of Science ®Google Scholar
• Kaas Q, Ruiz M, Lefranc MP. IMGT/3Dstructure-DB and IMGT/StructuralQuery, a database and a tool for immunoglobulin, T-cell receptor and MHC structural data. Nucleic Acids Res. 32, D208–D210 (2004).
   PubMed Web of Science ®Google Scholar
• Brusic V, Bajic VB, Petrovsky N. Computational methods for prediction of T-cell epitopes – a framework for modelling, testing, and applications. Methods 34(4), 436–443 (2004).
   PubMed Web of Science ®Google Scholar
• Hakenberg J, Nussbaum AK, Schild H et al. MAPPP: MHC class I antigenic peptide processing prediction. Appl. Bioinformatics 2(3), 155–158 (2003).
   PubMedGoogle Scholar
• Saxova P, Buus S, Brunak S, Kesmir C. Predicting proteasomal cleavage sites: a comparison of available methods. Int. Immunol. 15(7), 781–787 (2003).
   PubMed Web of Science ®Google Scholar
• Doytchinova I, Hemsley S, Flower DR. Transporter associated with antigen processing preselection of peptides binding to the MHC: a bioinformatic evaluation. J. Immunol. 173(11), 6813–6819 (2004).
   PubMed Web of Science ®Google Scholar
• Petrovsky N, Brusic V. Virtual models of the HLA class I antigen processing pathway. Methods 34(4), 429–435 (2004).
   PubMed Web of Science ®Google Scholar
• Bian H, Hammer J. Discovery of promiscuous HLA-II-restricted T-cell epitopes with TEPITOPE. Methods 34(4), 468–475 (2004).
   PubMed Web of Science ®Google Scholar
• De Groot AS, Jesdale B, Martin W et al. Mapping cross-clade HIV-1 vaccine epitopes using a bioinformatics approach. Vaccine 21(27–30), 4486–4504 (2003).
   PubMed Web of Science ®Google Scholar
• Doytchinova IA, Guan P, Flower DR. Quantitative structure-activity relationships and the prediction of MHC supermotifs. Methods 34(4), 444–453 (2004).
   PubMed Web of Science ®Google Scholar
• Srinivasan KN, Zhang GL, Khan AM, August JT, Brusic V. Prediction of class I T-cell epitopes: evidence of presence of immunological hot spots inside antigens. Bioinformatics 20(Suppl. 1), I297–I302 (2004).
   Web of Science ®Google Scholar
• Chao DL, Davenport MP, Forrest S, Perelson AS. A stochastic model of cytotoxic T-cell responses. J. Theor. Biol. 228(2), 227–240 (2004).
   PubMed Web of Science ®Google Scholar
• Borghans JAM, Beltman JB, De Boer RJ. MHC polymorphism under host–pathogen coevolution. Immunogenetics 55, 732–739 (2004).
   PubMed Web of Science ®Google Scholar
• Shahaf G, Allman D, Cancro MP, Mehr R. Screening of alternative models for transitional B-cell maturation. Int. Immunol. 16(8), 1081–1090 (2004).
   PubMed Web of Science ®Google Scholar
• Bernaschi M, Castiglione F. Design and implementation of an immune system simulator. Comput. Biol. Med. 31(5), 303–331 (2001).
   PubMed Web of Science ®Google Scholar
• Yates A, Chan CC, Callard RE, George AJ, Stark J. An approach to modelling in immunology. Brief Bioinform. 2(3), 245–257 (2001).
   PubMedGoogle Scholar
• Castiglione F, Poccia F, D’Offizi G, Bernaschi M. Mutation, fitness, viral diversity, and predictive markers of disease progression in a computational model of HIV Type 1 infection. AIDS Res. Hum. Retroviruses 20(12), 1314–1323 (2004).
   PubMedGoogle Scholar
• Schonbach C, Kowalski-Saunders P, Brusic V. Data warehousing in molecular biology. Brief Bioinform. 1(2), 190–198 (2000).
   PubMedGoogle Scholar
• Hu H, Brzeski H, Hutchins J et al. Biomedical informatics: development of a comprehensive data warehouse for clinical and genomic breast cancer research. Pharmacogenomics 5(7), 933–941 (2004).
   PubMedGoogle Scholar
• Sanchez W, Gilman B, Kher M, Lagou S, Covitz P. caGRID White Paper (cancer biomedical informatics grid prototype project). National Cancer Institute Center for Bioinformatics (NCICB), USA. July 23 (2004).
   Google Scholar
• Koenig-Hoffmann K, Bonin-Debs AL, Boche I et al. High throughput functional genomics: identification of novel genes with tumor suppressor phenotypes. Int. J. Cancer 20, 113(3), 434–439 (2005).
   PubMedGoogle Scholar
• Oh P, Li Y, Yu J et al. Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature 429(6992), 629–635 (2004).
   PubMed Web of Science ®Google Scholar
• Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin. Cancer Res. 10(21), 7252–7259 (2004).
   Google Scholar
• Glynne RJ, Watson SR. The immune system and gene expression microarrays – new answers to old questions. J. Pathol. 195(1), 20–30 (2001).
   PubMedGoogle Scholar
• Novellino L, Castelli C, Parmiani G. A listing of human tumor antigens recognized by T-cells: March 2004 update. Cancer Immunol. Immunother. 54(3), 187–207 (2005).
   PubMed Web of Science ®Google Scholar
• Dalgleish AG. Cancer vaccines as a therapeutic strategy. Expert Rev. Vaccines 3(6), 665–668 (2004).
   PubMedGoogle Scholar
• Motta S, Brusic V. Mathematical modelling of the immune system. In: Modelling in Molecular Biology. Ciobanu G, Rozenberg G (Eds), Natural Computing Series, Springer Verlag, Germany, 193–218 (2004).
   Google Scholar
• Persson L, Bartlett M. Notifiable Diseases Database system: review and development strategy. NSW Public Health Bull. 15(1–2), 10–12 (2004).
   PubMedGoogle Scholar
• Ferdinand S, Valetudie G, Sola C, Rastogi N. Data mining of Mycobacterium tuberculosis complex genotyping results using mycobacterial interspersed repetitive units validates the clonal structure of spoligotyping-defined families. Res. Microbiol. 155, 647–654 (2004).
   PubMedGoogle Scholar
• Kiechle FL, Zhang X, Holland-Staley CA. The -omics era and its impact. Arch. Pathol. Lab. Med. 128, 1337–1345 (2004).
   PubMed Web of Science ®Google Scholar
• Bodrossy L, Sessitsch A. Oligonucleotide microarrays in microbial diagnostics. Curr. Opin. Microbiol. 7(3), 245–254 (2004).
   PubMed Web of Science ®Google Scholar
• Mora M, Veggi D, Santini L, Pizza M, Rappuoli R. Reverse vaccinology. Drug Discov. Today 8(10), 459–464 (2003).
   PubMed Web of Science ®Google Scholar
• De Groot AS, Berzofsky JA. From genome to vaccine – new immunoinformatics tools for vaccine design. Methods 34(4), 425–428 (2004).
   PubMedGoogle Scholar
• Kellam P, Holzerlandt R, Gramoustianou E, Jenner R, Kwan A. Viral bioinformatics: computational views of host and pathogen. Novartis Found. Symp. 254, 234–247 (2003).
   PubMedGoogle Scholar
• Wodarz D. Mathematical models of HIV and the immune system. Novartis Found. Symp. 254, 193–207 (2003).
   PubMedGoogle Scholar
• Marino S, Kirschner DE. The human immune response to Mycobacterium tuberculosis in lung and lymph node. J. Theor. Biol. 227(4), 463–486 (2004).
   PubMed Web of Science ®Google Scholar
• Young K, Frodsham A, Doumbo OK et al. Inverse associations of human leukocyte antigen and malaria parasite types in two West African populations. Infect. Immun. 73(2), 953–955 (2005).
   PubMedGoogle Scholar
• Holcombe M. Computational models of cells and tissues: machines, agents and fungal infection. Brief Bioinform. 2(3), 271–278 (2001).
   PubMedGoogle Scholar
• Davies DH, Liang X, Hernandez JE et al. Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc. Natl Acad. Sci. USA 102(3), 547–552 (2005).
   PubMed Web of Science ®Google Scholar
• Rota PA, Oberste MS, Monroe SS et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300(5624), 1394–1399 (2003).
   PubMed Web of Science ®Google Scholar
• Scarselli M, Giuliani MM, Adu-Bobie J, Pizza M, Rappuoli R. The impact of genomics on vaccine design. Trends Biotech. 23(2), 84–91 (2005).
   PubMed Web of Science ®Google Scholar
• De Groot AS, Rappuoli R. Genome-derived vaccines. Expert Rev. Vaccines 3(1), 59–76 (2004).
   PubMedGoogle Scholar
• Sette A, Fleri W, Peters B, Sathiamurthy M, Bui HH, Wilson S. A roadmap for the immunomics of category A-C pathogens. Immunity (2005) (In Press).
   Google Scholar
• Locher CP, Soong NW, Whalen RG, Punnonen J. Development of novel vaccines using DNA shuffling and screening strategies. Curr. Opin. Mol. Ther. 6(1), 34–39 (2004).
   PubMed Web of Science ®Google Scholar
• Petrovsky N, Silva D, Brusic V. The future for computational modelling and prediction systems in clinical immunology. Novartis Found. Symp. 254, 23–32 (2003).
   PubMedGoogle Scholar
• Stadler MB, Stadler BM. Allergenicity prediction by protein sequence. FASEB J. 17(9), 1141–1143 (2003).
   PubMed Web of Science ®Google Scholar
• Soeria-Atmadja D, Zorzet A, Gustafsson MG, Hammerling U. Statistical evaluation of local alignment features predicting allergenicity using supervised classification algorithms. Int. Arch. Allergy Immunol. 133(2), 101–112 (2004).
   PubMed Web of Science ®Google Scholar
• Li, KB, Issac P, Krishnan A. Predicting allergenic proteins using wavelet transform. Bioinformatics 20(16), 2572–2578 (2004).
   PubMed Web of Science ®Google Scholar
• Fiers MW, Kleter GA, Nijland H, Peijnenburg AA, Nap JP, van Ham RC. Allermatch, a webtool for the prediction of potential allergenicity according to current FAO/WHO Codex alimentarius guidelines. BMC Bioinformatics 5(1), 133 (2004).
   PubMed Web of Science ®Google Scholar
• Gendel SM. Bioinformatics and food allergens. J. AOAC Int. 87(6), 1417–1422 (2004).
   PubMedGoogle Scholar
• Niederberger V, Valenta R. Genetically modified allergens. Immunol. Allergy Clin. North Am. 24(4), 727–738 (2004).
   PubMedGoogle Scholar
• Antonelli A, Tuomi T, Nannipieri M et al. Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes. Diabetologia 45(9), 1298–1306 (2002).
   PubMedGoogle Scholar
• Royle P, Bain L, Waugh N. Systematic reviews of epidemiology in diabetes: finding the evidence. BMC Med. Res. Methodol. 5(1), 2 (2005).
   PubMedGoogle Scholar
• Burren OS, Healy BC, Lam AC et al. Development of an integrated genome informatics, data management and workflow infrastructure: a toolbox for the study of complex disease genetics. Hum. Genomics 1(2), 98–109 (2004).
   PubMedGoogle Scholar
• Weinstock-Guttman B, Jacobs LD, Brownscheidle CM et al. Multiple sclerosis characteristics in African American patients in the New York State Multiple Sclerosis Consortium. Mult. Scler. 9(3), 293–298 (2003).
   PubMed Web of Science ®Google Scholar
• Lund IK, Andersen HS, Iversen LF et al. Structure-based design of selective and potent inhibitors of protein-tyrosine phosphatase beta. J. Biol. Chem. 279(23), 24226–24235 (2004).
   PubMedGoogle Scholar
• Flynn JC, McCormick DJ, Brusic V et al. Pathogenic human thyroglobulin peptides in HLA-DR3 transgenic mouse model of autoimmune thyroiditis. Cell. Immunol. 229(2), 79–85 (2004).
   PubMed Web of Science ®Google Scholar
• Teo YM, Wang X, Ng YK. GLAD: a system for developing and deploying large-scale bioinformatics grid. Bioinformatics (2005) (In Press).
   Google Scholar
• Srinivasan KN, Brusic V, August JT. New technologies for vaccine development. Drug Dev. Res. 62, 383–392 (2004).
   Google Scholar
• Kantor AB, Alters SE, Cheal K, Dietz LJ. Immune systems biology: immunoprofiling of cells and molecules. Biotechniques 36(3), 520–524 (2004).
   PubMedGoogle Scholar
• Liang H, Cordova SE, Kieft TL, Rogelj S. A highly sensitive immuno-PCR assay for detecting Group A Streptococcus. J. Immunol. Methods 279(1–2), 101–110 (2003).
   PubMed Web of Science ®Google Scholar
• Liu F, Guttikonda S, Suresh MR. Bispecific monoclonal antibodies against a viral and an enzyme: utilities in ultrasensitive virus ELISA and phage display technology. J. Immunol. Methods 274(1–2), 115–127 (2003).
   PubMedGoogle Scholar
  Pappalardo F, Lollini PL, Castiglione F, Motta S. Modeling and simulation of cancer immunoprevention vaccine. Bioinformatics (2005) (In Press).
   Google Scholar